Based on his rash onset with atezolizumab and rapid recrudescence with PD-1 inhibitor pembrolizumab, classic cutaneous morphology and psoriatic arthritis diagnosis, he was diagnosed with PD-L1/PD-1-induced psoriasis/psoriatic arthritis. This evidence concerns the gene CD274 and psoriatic arthritis.